Results 141 to 150 of about 49,427 (236)

Classification and Personalized Prognosis in Myeloproliferative Neoplasms [PDF]

, 2018
Jacob Grinfeld, Jyoti Nangalia, E. Joanna Baxter, David C. Wedge, Nicos Angelopoulos, R. Cantrill, Anna L. Godfrey, Elli Papaemmanuil, Gunes Gundem, Cathy MacLean, Julia Cook, Laura O’Neil, Sarah O’Meara, Jon W. Teague, Adam P. Butler, Charlie E. Massie, Nicholas Williams, Francesca Nice, Christen Lykkegaard Andersen, Hans Carl Hasselbalch, Paola Guglielmelli, Mary Frances McMullin, Alessandro M. Vannucchi, Claire Harrison, Moritz Gerstung, Anthony R. Green, Peter J. Campbell   +26 more
openalex   +1 more source

Molecular screening for an underlying myeloproliferative neoplasm in rheumatology patients

, 2022
Stephen E. Langabeer
openalex   +2 more sources

STK405759 targets microtubules, modulates STAT1, and enhances ruxolitinib efficacy in myeloproliferative neoplasms. [PDF]

Am J Cancer Res
Rozic G, Makaros Y, Shapira-Netanelov I, Kardash T, Maizels Y, Koman I, Leiba M, Duek A.   +7 more
europepmc   +1 more source

The Dual Role of Interferon Signaling in Myeloproliferative Neoplasms: Pathogenesis and Targeted Therapeutics. [PDF]

Cancers (Basel)
Bonuomo V, Dogliotti I, Masucci S, Grano S, Savi A, Frolli A, Cilloni D, Fava C.   +7 more
europepmc   +1 more source

Supplementary Figure S5 from Jak2^V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms

Andrew Dunbar, Robert L. Bowman, Young C. Park, Kavi O’Connor, Franco Izzo, Robert M. Myers, Abdul Karzai, Zachary Zaroogian, Won Jun Kim, Inés Fernández-Maestre, Michael R. Waarts, Abbas Nazir, Wenbin Xiao, Tamara Codilupi, Max Brodsky, Mirko Farina, Louise Cai, Sheng F. Cai, Benjamin Wang, Wenbin An, Julie L. Yang, Shoron Mowla, Shira E. Eisman, Amritha Varshini Hanasoge Somasundara, Jacob L. Glass, Tanmay Mishra, Remie Houston, Emily Guzzardi, Anthony R. Martinez Benitez, Aaron D. Viny, Richard P. Koche, Sara C. Meyer, Dan A. Landau, Ross L. Levine   +33 more
openalex   +1 more source

Proteostasis alterations in myeloproliferative neoplasms: Oncogenic relevance and therapeutic opportunities

, 2016
Olaya Santiago‐Fernández, Fernando G. Osorio, Carlos López-Otı́n   +2 more
openalex   +2 more sources

Outcomes of Cerebral Venous Thrombosis in Patients With Myeloproliferative Neoplasms from a U.S. Nationwide Hospitalization Study. [PDF]

EJHaem
Vojjala N, Shah R, Gibatova V, Kattamuri L, Agrawal S, Krishnamoorthy G, Patell R.   +6 more
europepmc   +1 more source

Long-Term Safety Profile of Ruxolitinib in Chronic Myeloproliferative Neoplasms: A Comprehensive Real-World Analysis. [PDF]

EJHaem
Blanco-Sánchez A, Ayala R, Carreño-Tarragona G, Colmenares R, López-Muñoz N, Sáez A, Palacios-Berraquero ML, Hernández J, Martínez-López J.   +8 more
europepmc   +1 more source

Gender influences prognosis of classical BCR::ABL1 negative myeloproliferative neoplasms: a retrospective cohort study. [PDF]

Discov Oncol
Cai Y, Wang Y, Zhang P, Zhu Z.
europepmc   +1 more source

Molecular genetics of BCR-ABL1 negative myeloproliferative neoplasms in India

, 2018
Nikhil Rabade, PG Subramanian, Rohan Kodgule, Goutham Raval, Swapnali Joshi, Shruti Chaudhary, Russel Mascarenhas, Prashant Tembhare, Sumeet Gujral, Nikhil Patkar   +9 more
openalex   +1 more source